HR Execs on the Move

Pyramid Healthcare

www.pyramidhealthcarepa.com

 
A premier provider of high quality, behavioral health care founded in 1999 and headquartered in central Pennsylvania, we operate over 80 facilities across the Commonwealth, New Jersey, and North Carolina and offer a full continuum of mental health, treatment and recovery services for adults and teens. Our dedicated admissions representatives are available to schedule confidential assessments and admissions, recommend appropriate treatment options, assist with insurance verification and facilitate complimentary transportation to and from our detox and inpatient program locations.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Brian Winterstein
EVP, Chief Human Resources Officer Profile

Similar Companies

Blood Systems

Blood Systems is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

US Orthopedic Alliance

Leverage our resources to scale your practice, while maintaining your independence.

Sleep Disorder Center of Louisiana

Sleep Disorder Center of Louisiana is a Lake Charles, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Averion International Corporation

Averion International Corporation is a Southborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.